Company / Cost of Revenue
Zimmer Biomet Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$2.5B
FY2025
5-year range
$2.0B / $2.5B
FY2021-FY2025
Trend
+13.8%
vs FY2024
Sector context
#27 of 113
Health Care
What the data says
Zimmer Biomet's cost of revenue of $2.5B is higher than 76% of companies in the Health Care sector (FY2025). Cost of Revenue has increased for 5 consecutive years, from $1.8B in FY2020 to $2.5B in FY2025.
Based on SEC 10-K filings.
$2.5B in FY2025 with a 5-year CAGR of +6.5%. Top quartile in the Health Care sector.
Increased from $2.1B to $2.5B over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +7.3%
- 5-Year CAGR
- +6.5%
- 10-Year CAGR
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 113This company $2.5B Sector average $11.3B
▼
-77.9% below sector average
Key checks
Key Insights
- Zimmer Biomet's cost of revenue has grown for 5 consecutive years.
- 5-year CAGR of +6.5%, indicating consistent growth.
- In FY2025, cost of revenue increased 13.8% year-over-year.
- Ranks #27 out of 113 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.5B | +13.8% |
| FY2024 | $2.2B | +5.2% |
| FY2023 | $2.1B | +3.2% |
| FY2022 | $2.0B | +3.0% |
| FY2021 | $2.0B | +7.5% |
| FY2020 | $1.8B | -14.5% |
| FY2019 | $2.1B | -10.5% |
| FY2018 | $2.4B | +11.7% |
| FY2017 | $2.1B | +71.6% |
| FY2016 | $1.2B | -31.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026